INTEGRATED BIOPHARMA INC (INBP) Free cash flow 2016–2025
INTEGRATED BIOPHARMA INC (INBP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.9MFY2025 · since FY2016: -$703,000 → $1.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.9M | +380.5% |
| FY2024 | $390,000 | -65.1% |
| FY2023 | $1.1M | -69.0% |
| FY2022 | $3.6M | +30.9% |
| FY2021 | $2.8M | +144.9% |
| FY2020 | $1.1M | +1408.1% |
| FY2019 | -$86,000 | -109.3% |
| FY2018 | $921,000 | +1215.7% |
| FY2017 | $70,000 | +110.0% |
| FY2016 | -$703,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice